NeuroBo Pharmaceuticals Inc (NRBO)
2.40
+0.05
(+2.13%)
USD |
NASDAQ |
Nov 22, 15:52
NeuroBo Pharmaceuticals Max Drawdown (5Y): 100.00% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 100.00% |
| September 30, 2024 | 100.00% |
| August 31, 2024 | 100.00% |
| July 31, 2024 | 100.00% |
| June 30, 2024 | 100.00% |
| May 31, 2024 | 100.00% |
| April 30, 2024 | 100.00% |
| March 31, 2024 | 100.00% |
| February 29, 2024 | 100.00% |
| January 31, 2024 | 100.00% |
| December 31, 2023 | 100.00% |
| November 30, 2023 | 100.00% |
| October 31, 2023 | 100.00% |
| September 30, 2023 | 100.00% |
| August 31, 2023 | 100.00% |
| July 31, 2023 | 100.00% |
| June 30, 2023 | 100.00% |
| May 31, 2023 | 99.99% |
| April 30, 2023 | 99.99% |
| March 31, 2023 | 99.99% |
| February 28, 2023 | 99.99% |
| January 31, 2023 | 99.99% |
| December 31, 2022 | 99.99% |
| November 30, 2022 | 99.98% |
| October 31, 2022 | 99.92% |
| Date | Value |
|---|---|
| September 30, 2022 | 99.92% |
| August 31, 2022 | 99.92% |
| July 31, 2022 | 99.92% |
| June 30, 2022 | 99.92% |
| May 31, 2022 | 99.92% |
| April 30, 2022 | 99.89% |
| March 31, 2022 | 99.86% |
| February 28, 2022 | 99.86% |
| January 31, 2022 | 99.81% |
| December 31, 2021 | 99.77% |
| November 30, 2021 | 99.71% |
| October 31, 2021 | 99.66% |
| September 30, 2021 | 99.48% |
| August 31, 2021 | 99.48% |
| July 31, 2021 | 99.48% |
| June 30, 2021 | 99.48% |
| May 31, 2021 | 99.48% |
| April 30, 2021 | 99.41% |
| March 31, 2021 | 99.25% |
| February 28, 2021 | 99.19% |
| January 31, 2021 | 99.05% |
| December 31, 2020 | 99.05% |
| November 30, 2020 | 99.05% |
| October 31, 2020 | 99.05% |
| September 30, 2020 | 98.97% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
98.49%
Minimum
Nov 2019
100.00%
Maximum
Jun 2023
99.59%
Average
99.90%
Median
Max Drawdown (5Y) Benchmarks
| Dermata Therapeutics Inc | -- |
| Cognition Therapeutics Inc | -- |
| ZyVersa Therapeutics Inc | -- |
| Cytokinetics Inc | 55.71% |
| Ocugen Inc | 99.96% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -73.04 |
| Beta (5Y) | -0.2622 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 106.8% |
| Historical Sharpe Ratio (5Y) | -0.7156 |
| Historical Sortino (5Y) | -1.279 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 50.11% |